Chimeric antigen receptor T cell therapy for glioblastoma: overcoming current barriers and strategies to enhance efficacy for therapeutic implications
{{output}}
Glioblastoma (GBM) is a highly malignant primary brain tumor, characterized by limited therapeutic options and poor survival outcomes. Nevertheless, its treatment is significantly hampered by the immunosuppressive tumor microenvironment, tumor antigen heteroge... ...
